Skip to main content

Advertisement

SpringerLink
Log in

Hereditary diffuse gastric cancer: cancer risk and the personal cost of preventive surgery

  • Original Article
  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Germline CDH1 mutation carriers are at risk for early-onset diffuse gastric cancer (DGC) and female carriers have an additional risk of lobular breast cancer. The reported literature GC risk of 70% has led to the recommendation for germline mutation carriers to undergo prophylactic total gastrectomy (PTG). The objective of this research was to examine post-surgical clinical outcomes and to identify which of the domains/symptoms from the European Organisation for Research and Treatment of Cancer QOL Questionnaire (EORTC QLQ-C30) were determinants of overall quality of life (QOL) in individuals undergoing PTG. Participants were recruited through multiple sources. Postsurgical clinical outcomes were obtained from hospital records. Participants completed validated questionnaires measuring generic and condition specific QOL (PROMIS, EORTC and SF 36v.II) at a single point in time. The mean QOL in this cohort was 70.6 (SD = 25.6), which is better than reference values from the general populations in USA and Canada Role and social function plus the symptoms anxiety, pain, taste, dyspnea and diarrhea were significant predictor variables for QOL (p < 0.05). Although this study reveals good overall QOL for individuals after PTG, attention should be given to managing symptoms as part of long term care to further enhance QOL. The function/symptom scores were associated with worse overall health and global health status and thus may mark a real need for more attentive post-surgical care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Hansford S, Kaurah P, Li-Chang H, Woo M, Senz J, Pinheiro H, Schrader KA, Schaeffer DF, Shumansky K, Zogopoulos G, Santos TA, Claro I, Carvalho J, Nielsen C, Padilla S, Lum A, Talhouk A, Baker-Lange K, Richardson S, Lewis I, Lindor NM, Pennell E, MacMillan A, Fernandez B, Keller G, Lynch H, Shah SP, Guilford P, Gallinger S, Corso G, Roviello F, Caldas C, Oliveira C, Pharoah PD, Huntsman DGDG (2015) Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol 1(1):23–32. https://doi.org/10.1001/jamaoncol.2014.168

    Article  PubMed  Google Scholar 

  2. van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O’Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC (2015) Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 52(6):361–374. https://doi.org/10.1136/jmedgenet-2015-103094 (Epub 2015 May 15)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, Hayashi A, Monaghan KG, Maung R, Seruca R, Jackson CE, Caldas C (2001) Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 344(25):1904–1909

    Article  CAS  Google Scholar 

  4. Lewis FR, Mellinger JD, Hayashi A, Lorelli D, Monaghan KG, Carneiro F, Huntsman DG, Jackson CE, Caldas C (2001) Prophylactic total gastrectomy for familial gastric cancer. Surgery 130(4):612–617 (discussion 617-9)

    Article  CAS  Google Scholar 

  5. Chun YS, Lindor NM, Smyrk TC, Petersen BT, Burgart LJ, Guilford PJ, Donohue JH (2001) Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer 92(1):181–187

    Article  CAS  Google Scholar 

  6. Newman EA, Mulholland MW (2006) Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome. J Am Coll Surg 202(4):612–617

    Article  Google Scholar 

  7. Norton JA, Ham CM, Van Dam J, Jeffrey RB, Longacre TA, Huntsman DG, Chun N, Kurian AW, Ford JM (2007) CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg 245(6):873

    Article  Google Scholar 

  8. Hebbard PC, Macmillan A, Huntsman D, Kaurah P, Carneiro F, Wen X, Kwan A, Boone D, Bursey F, Green J, Fernandez B, Fontaine D, Wirtzfeld DA (2009) Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients. Ann Surg Oncol 16(7):1890–1895

    Article  CAS  Google Scholar 

  9. Hackenson D, Edelman DA, McGuire T, Weaver DW, Webber JD (2010) Prophylactic laparoscopic gastrectomy for hereditary diffuse gastric cancer: a case series in a single family. JSLS J Soc Laparoendosc Surg 14(3):348. https://doi.org/10.4293/108680810x12924466007449

    Article  Google Scholar 

  10. Pandalai PK, Lauwers GY, Chung DC, Patel D, Yoon SS (2011) Prophylactic total gastrectomy for individuals with germline CDH1 mutation. Surgery 149(3):347–355

    Article  Google Scholar 

  11. Chen Y, Kingham K, Ford JM, Rosing J, Van Dam J, Jeffrey RB, Longacre TA, Chun N, Kurian A, Norton JA (2011) A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Ann Surg Oncol 18(9):2594–2598. https://doi.org/10.1245/s10434-011-1648-9 (Epub 2011 Mar 18)

    Article  PubMed  Google Scholar 

  12. Li J, McBean E, Li X, Berho M, Szomstein S, Rosenthal RJ (2013) Laparoscopic prophylactic total gastrectomy with linear stapler side-to-side esophagojejunal anastomosis for hereditary diffuse gastric cancer syndrome in 2 siblings. Surg Laparosc Endosc Percutaneous Tech 23(3):e124–e126. https://doi.org/10.1097/SLE.0b013e3182773e38

    Article  Google Scholar 

  13. Bardram L, Hansen TV, Gerdes AM, Timshel S, Friis-Hansen L, Federspiel B (2014) Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations—a clinical observational study. Fam Cancer 13(2):231–242. https://doi.org/10.1007/s10689-013-9698-8

    Article  CAS  PubMed  Google Scholar 

  14. Worster E, Liu X, Richardson S, Hardwick RH, Dwerryhouse S, Caldas C, Fitzgerald RC (2014) The impact of prophylactic total gastrectomy on health-related quality of life: a prospective cohort study. Ann Surg 260(1):87–93

    Article  Google Scholar 

  15. Muir J, Aronson M, Esplen MJ, Pollett A, Swallow CJ (2016) Prophylactic total gastrectomy: a prospective cohort study of long-term impact on quality of life. J Gastrointest Surg 20(12):1950–1958 (Epub 2016 Oct 17)

    Article  Google Scholar 

  16. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376

    Article  CAS  Google Scholar 

  17. Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O et al (2004) Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer 40(15):2260–2268

    Article  CAS  Google Scholar 

  18. Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D, PROMIS Cooperative Group (2011) Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger. Assessment 18(3):263–283

    Article  Google Scholar 

  19. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) EORTC QLQ-C30 Scoring Manual

  20. Nolte S, Liegl G, Petersen MA, Aaronson NK, Costantini A, Fayers PM, Groenvold M, Holzner B, Johnson CD, Kemmler G, Tomaszewski KA, Waldmann A, Young TE, Rose M, EORTC Quality of Life Group (2019) General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States. Eur J Cancer 107:153–163

    Article  CAS  Google Scholar 

  21. Ferrans CE, Powers MJ (1993) Quality of life of hemodialysis patients. Anna J 20(5):575–581 (discussion 582)

    CAS  PubMed  Google Scholar 

  22. Strong VE, Gholami S, Shah MA, Tang LH, Janjigian YY, Schattner M, Selby LV, Yoon SS, Salo-Mullen E, Stadler ZK, Kelsen D, Brennan MF, Coit DG (2017) Total gastrectomy for hereditary diffuse gastric cancer at a single center: postsurgical outcomes in 41 patients. Ann Surg 266(6):1006–1012. https://doi.org/10.1097/SLA.0000000000002030

    Article  PubMed  Google Scholar 

  23. Jakstaite G, Samalavicius NE, Smailyte G, Lunevicius R (2012) The quality of life after a total gastrectomy with extended lymphadenectomy and omega type oesophagojejunostomy for gastric adenocarcinoma without distant metastases. BMC Surg 12(1):11. https://doi.org/10.1186/1471-2482-12-11

    Article  PubMed  PubMed Central  Google Scholar 

  24. Diaz De Liano A, Oteiza Martinez F, Ciga MA, Aizcorbe M, Cobo F, Trujillo R (2003) Impact of surgical procedure for gastric cancer on quality of life. Br J Surg 90(1):91–94

    Article  CAS  Google Scholar 

  25. Rocha JP, Gullo I, Wen X, Devezas V, Baptista M, Oliveira C, Carneiro F (2018) Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management. Histopathology 73(6):878–886 (Epub 2018 Oct 9. Review)

    Article  Google Scholar 

  26. Tichansky DS, Boughter JD Jr, Madan AK (2006) Taste change after laparoscopic Roux-en-Y gastric bypass and laparoscopic adjustable gastric band. Surg Obes Relat Dis 2:440–444

    Article  Google Scholar 

  27. Harris AM, Griffin SM (2003) Postoperative taste and smell deficit after upper gastrointestinal cancer surgery—an unreported complication. J Surg Oncol 82:147–150

    Article  Google Scholar 

  28. Carey S, Laws R, Ferrie S, Young J, Allman-Farinelli M (2013) Struggling with food and eating—life after major upper gastrointestinal surgery. Support Care Cancer 21:2749–2757

    Article  Google Scholar 

  29. Kroenke K, Yu Z, Wu J, Kean J, Monahan PO (2014) Operating characteristics of PROMIS four-item depression and anxiety scales in primary care patients with chronic pain. Pain Med 15(11):1892–1901. https://doi.org/10.1111/pme.12537 (Epub 2014 Aug 19)

    Article  PubMed  PubMed Central  Google Scholar 

  30. Maeda T, Onuoha FN, Munakata T (2006) The effect of postoperative symptom experience, and personality and psychosocial factors on depression among postgastrectomy patients in Japan. Gastroenterol Nurs 29(6):437–444

    Article  Google Scholar 

  31. Brown LF, Kroenke K, Theobald DE, Wu J, Tu W (2010) The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psycho-Oncology 19(7):734–741. https://doi.org/10.1002/pon.1627

    Article  PubMed  PubMed Central  Google Scholar 

  32. Brintzenhofe-Szoc KM, Levin TT, Li Y, Kissane DW, Zabora JR (2009) Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics 50:383–391

    Article  Google Scholar 

  33. Stark D, Kiely M, Smith A, Velikova G, House A, Selby P (2002) Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol 20(14):3137–3148

    Article  CAS  Google Scholar 

  34. Kim AR, Cho J, Hsu YJ, Choi MG, Noh JH, Sohn TS, Bae JM, Yun YH, Kim S (2012) Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg 256(6):1008–1013

    Article  Google Scholar 

  35. Kobayashi D, Kodera Y, Fujiwara M, Koike M, Nakayama G, Nakao A (2011) Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg 35(2):357–364

    Article  Google Scholar 

  36. Huang JL, Wei HB, Zheng ZH, Wei B, Chen TF, Huang Y, Guo WP, Hu B (2010) Laparoscopy-assisted D2 radical distal gastrectomy for advanced gastric cancer. Dig Surg 27(4):291–296. https://doi.org/10.1159/000281818 (Epub 2010 Jul 31)

    Article  PubMed  Google Scholar 

  37. Wu CW, Chiou JM, Ko FS, Lo SS, Chen JH, Lui WY, Whang-Peng J (2008) Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial. Br J Cancer 98(1):54–59

    Article  Google Scholar 

  38. Kong H, Kwon OK, Yu W (2012) Changes of quality of life after gastric cancer surgery. J Gastric Cancer 12(3):194–200. https://doi.org/10.5230/jgc.2012.12.3.194 (Epub 2012 Sep 30)

    Article  PubMed  PubMed Central  Google Scholar 

  39. Cohen S, Wills TA (1985) Stress, social support, and the buffering hypothesis. Psychol Bull 98(2):310

    Article  CAS  Google Scholar 

  40. Tian J, Hong JS (2014) Assessment of the relationship between resilience and quality of life in patients with digestive cancer. World J Gastroenterol WJG 20(48):18439. https://doi.org/10.3748/wjg.v20.i48.18439

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada

    P. Kaurah & D. Huntsman

  2. Hereditary Cancer Program, BC Cancer Agency, Vancouver, BC, Canada

    P. Kaurah

  3. Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada

    A. Talhouk & D. Huntsman

  4. Provincial Medical Genetics Program, St John’s, NF, Canada

    A. MacMillan & I. Lewis

  5. No Stomach For Cancer Inc., Madison, WI, USA

    K. Chelcun-Schreiber

  6. Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    S. S. Yoon

Authors
  1. P. Kaurah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Talhouk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. MacMillan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Chelcun-Schreiber
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. S. Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Huntsman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to P. Kaurah or D. Huntsman.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaurah, P., Talhouk, A., MacMillan, A. et al. Hereditary diffuse gastric cancer: cancer risk and the personal cost of preventive surgery. Familial Cancer 18, 429–438 (2019). https://doi.org/10.1007/s10689-019-00133-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-019-00133-9

Keywords

Search

Navigation